March 19, 2012
CASE CCC IN THE NEWS
Cleveland Clinic Geneticist: We Need More People Who Can Explain Genetic Data to Patients
Multiple Myeloma: Relapsed and Refractory Patients, a Clinical Context Report
Ohio Legislator Wants Insurance Coverage to be Same for Oral, Injectable Chemotherapy Treatments
Detecting Colon Cancer Early Can Save Your Life: NetWellness
New Pathway Found for Regulation of Blood Vessel Growth in Cancer
New Tool to Help with Prognosis of Patients with Brain Metastases
MARK YOUR CALENDARS
Case CCC Clinical Research Retreat
Registration is open for the Case CCC Clinical Research Retreat, April 4 in the Dively Building on CWRU campus. An opening reception will start at 5:30 pm, followed by dinner and presentations from 6-8:30 pm.
The agenda will focus on new initiatives of critical importance to clinical investigators. Topics will include:
Register today for Informatics: Driving Discovery, Improving Health (IDD 2012), April 6 in the Wolstein Research Building. This symposium, sponsored by CWRU and Clinical and Translational Science Collaborative (CTSC), brings together all the disciplines involved in clinical and translational research for the shared benefits of networking and education.
Symposium themes will focus on the application and impact of information technology, such as:
A discounted registration rate of $30 is available for students and CTSC/Cancer Center members.
Case CCC Scientific Series
Please mark your calendars for the next installments of the Case CCC Scientific Series:
These extended conferences feature recent scientific investigation from our members, featuring presentations by investigators who received pilot funding after competitive peer review by the Cancer Center. Please make every effort to attend.
BETRNet Pilot Funding
Faculty members with an appointment at the Assistant Professor level or higher at participating institutions are invited to submit applications for individual and/or cross Barrett's Esophagus Translational Research Network (BETRNet) pilot projects. Participating institutions include CWRU, University of Pennsylvania, Fred Hutchinson Cancer Research Center, Johns Hopkins, University North Carolina, Washington University, and Mayo Clinic. BETRNet projects must be directed toward translational research related to Barrett's Esophagus or Esophageal Adeno Cardinoma. At least one specific aim should involve either direct patient contact or the study of patient derived tissue samples.
Deadline: May 18
The Doctors Cancer Foundation
The Doctors Cancer Foundation, Inc., is a non-profit corporation that has been formed to provide seed money for promising new concepts in cancer research. By supporting research projects seeking to find new principles of cancer management, the Foundation will encourage scientists to identify and explore untested forms of treatment and ultimately enhance the quality of care for the people who have cancer. The Foundation is accepting applications for the 2012 funding cycle. There is a strong interest in cancer stem cells, microRNAi agents, epigenetic agents, as well as many others. They are particularly interested in promoting the best of the young scientists, currently under the radar screen.
Deadline: May 31
HHMI Investigator Program Announces National Competition
The Howard Hughes Medical Institute (HHMI) invites applications for investigator positions from outstanding scientists who have demonstrated originality and substantial accomplishments in biomedical research and who show exceptional promise for future achievement and leadership in research. The Institute expects to appoint between 20-30 new investigators.
This HHMI investigator competition is open to scientists who study significant biological problems in all of the biomedical disciplines as well as in adjacent fields such as biophysics, chemical biology, biomedical engineering, and computational biology. Plant scientists, experimental evolutionary biologists, and patient-oriented researchers are welcome to apply to this competition.
Deadline to establish eligibility: May 1
NCI Annual Report on Complementary and Alternative Medicine: FY2010 Released
The NCI Annual Report on Complementary and Alternative Medicine: FY2010 was recently released. This report is produced by the Office of Cancer Complementary and Alternative Medicine (OCCAM), which is an office of the NCI in the Division of Cancer Treatment and Diagnosis. OCCAM is responsible for NCI's research agenda in complementary and alternative medicine (CAM) as it relates to cancer prevention, diagnosis, treatment, and symptom management.
CWRU investigators Drs. Subrata Haldar and Aruna Basu are highlighted in the section on "Accelerating Progress in Cancer Prevention" for their research of whether the compound benzyl isothiocyanate (BITC), which is produced when digesting certain cruciferous vegetables, may be used to prevent or treat pancreatic cancer. Preliminary results have been promising, and have shown BITC alters the levels of microRNA in pancreatic cancer cells, and may be effective in slowing the growth of these cells.
**All events are open to anyone interested in attending
Physiology and Biophysics Seminar
F. Joseph Callahan Distinguished Lecture
Department of Cancer Biology Invited Speaker Seminar
Immunology Seminar Series
Molecular Biology and Microbiology Thesis Presentation
Hematology and Oncology Division Research Conference
Immunology Faculty Research in Progress Seminar
Cancer Center Faculty Candidate Seminar
Molecular Biology and Microbiology Seminar
Sternlicht Memorial Lectureship in Cancer Biology and Pharmacology
Taussig Cancer Institute Grand Rounds
Cancer Center Seminar Series
Cancer Center Research in Progress Seminar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Ca-PRI Annual Meeting: Learning from Our Differences
ADDITIONAL UPCOMING SEMINARS & EVENTS
Grant Writing and Reviewing Workshop
Department of Biomedical Engineering Special Seminar
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES
American Legacy Foundation Sybil G. Jacobs Award for Outstanding Use of Tobacco Industry Documents
DOD Ovarian Cancer Research Program Teal Innovator Award
NIH BULLETIN – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to email@example.com.